日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody

对一种广谱中和SARS-CoV-2抗体的功能和结构研究

Yi-Hsuan Chang ,Min-Feng Hsu ,Wei-Nan Chen ,Min-Hao Wu ,Wye-Lup Kong ,Mei-Yeh Jade Lu ,Chih-Heng Huang ,Fang-Ju Chang ,Lan-Yi Chang ,Ho-Yang Tsai ,Chao-Ping Tung ,Jou-Hui Yu ,Yali Kuo ,Yu-Chi Chou ,Li-Yang Bai ,Yuan-Chih Chang ,An-Yu Chen ,Cheng-Cheung Chen ,Yi-Hua Chen ,Chun-Che Liao ,Chih-Shin Chang ,Jian-Jong Liang ,Yi-Ling Lin ,Takashi Angata ,Shang-Te Danny Hsu ,Kuo-I Lin

Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants

开发针对SARS-CoV-2变异株的AAV递送的广谱中和抗人ACE2抗体

Cheng-Pu Sun,Chi-Wen Chiu,Ping-Yi Wu,Szu-I Tsung,I-Jung Lee,Chih-Wei Hu,Min-Feng Hsu,Tzu-Jiun Kuo,Yu-Hua Lan,Li-Yao Chen,Hui-Yee Ng,Meng-Jhe Chung,Hsin-Ni Liao,Sheng-Che Tseng,Chia-Hui Lo,Yung-Jiun Chen,Chun-Che Liao,Chih-Shin Chang,Jian-Jong Liang,Piotr Draczkowski,Sarita Puri,Yuan-Chih Chang,Jing-Siou Huang,Cheng-Cheung Chen,Jyh-Hwa Kau,Yen-Hui Chen,Wen-Chun Liu,Han-Chung Wu,Shang-Te Danny Hsu,I-Hsuan Wang,Mi-Hua Tao

Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission

人类 ACE2 蛋白是控制 SARS-CoV-2 传播方式的分子开关

Chao-Fu Yang, Chun-Che Liao #, Hung-Wei Hsu #, Jian-Jong Liang #, Chih-Shin Chang, Hui-Ying Ko, Rue-Hsin Chang, Wei-Chun Tang, Ming-Hao Chang, I-Hsuan Wang, Yi-Ling Lin

A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern

一种基于受体结合域的纳米颗粒疫苗可诱导产生针对SARS-CoV-2及其相关变种的持久中和抗体反应。

Lee, I-Jung; Lan, Yu-Hua; Wu, Ping-Yi; Wu, Yan-Wei; Chen, Yu-Hung; Tseng, Sheng-Che; Kuo, Tzu-Jiun; Sun, Cheng-Pu; Jan, Jia-Tsrong; Ma, Hsiu-Hua; Liao, Chun-Che; Liang, Jian-Jong; Ko, Hui-Ying; Chang, Chih-Shin; Liu, Wen-Chun; Ko, Yi-An; Chen, Yen-Hui; Sie, Zong-Lin; Tsung, Szu-I; Lin, Yi-Ling; Wang, I-Hsuan; Tao, Mi-Hua

Optimization and Improvement of qPCR Detection Sensitivity of SARS-CoV-2 in Saliva

优化和提高唾液中SARS-CoV-2的qPCR检测灵敏度

Ko, Hui-Ying; Li, Yao-Tsun; Li, Ya-Yuan; Chiang, Ming-Tsai; Lee, Yi-Ling; Liu, Wen-Chun; Liao, Chun-Che; Chang, Chih-Shin; Lin, Yi-Ling

Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan

SARS-CoV-2感染后纵向中和抗体反应:台湾一项康复队列研究

Huang, Yen-Fang; Hsu, Fang-Chi; Wu, Jiunn-Jong; Lin, Yi-Ling; Liu, Ming-Tsan; Yang, Chin-Hui; Kuo, Hsu-Sung; Chen, Yen-Ju; Cheng, Chien-Yu; Lin, His-Hsun; Liao, Chun-Che; Chang, Chih-Shin; Liang, Jian-Jong; Cheng, Wen-Yueh; Huang, Jason C; Chen, Cheng-Pin; Cheng, Shu-Hsing; Lin, Yi-Chun; Yang, Shung-Haur; Chou, Yiing-Jenq

Regression of advanced maxillary sinus cancer with orbital invasion by combined chemotherapy and immunotherapy: A one-year follow-up case report

化疗联合免疫疗法使伴有眼眶侵犯的晚期上颌窦癌消退:一例一年随访病例报告

Kuo, Yu-Hsuan; Lin, Chih-Shin

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan

台湾标准 ChAdOx1 nCoV-19 疫苗的体液免疫原性和反应原性

Jer-Hwa Chang, Jeng-Fong Chiou, Ching-Sheng Hung, Ming-Che Liu, Hui-Wen Chang, Shiao-Ya Hong, Cheng-Yi Wang, Yi-Ling Lin, Yi-Chen Hsieh, Chi-Li Chung, Ying-Shih Su, Shu-Tai Shen Hsiao, Doresses Liu, Jian-Jong Liang, Chun-Che Liao, Chih-Shin Chang, Kevin Shu-Leung Lai, Han-Chuan Chuang, Ko-Ling Chien

Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan

CpG 1018 和氢氧化铝佐剂 SARS-CoV-2 S-2P 蛋白疫苗 MVC-COV1901 的安全性和免疫原性:台湾一项大规模、双盲、随机、安慰剂对照 II 期试验的中期结果

Hsieh, Szu-Min; Liu, Ming-Che; Chen, Yen-Hsu; Lee, Wen-Sen; Hwang, Shinn-Jang; Cheng, Shu-Hsing; Ko, Wen-Chien; Hwang, Kao-Pin; Wang, Ning-Chi; Lee, Yu-Lin; Lin, Yi-Ling; Shih, Shin-Ru; Huang, Chung-Guei; Liao, Chun-Che; Liang, Jian-Jong; Chang, Chih-Shin; Chen, Charles; Lien, Chia En; Tai, I-Chen; Lin, Tzou-Yien

Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model

在新的免疫功能正常的小鼠模型中对 EV-A71 进行缺氧治疗并使用免疫调节剂 TLR7 激动剂进行治疗

An-Ting Liou, Chun-Che Liao, Shu-Fan Chou, Ya-Shu Chang, Chih-Shin Chang, Chiaho Shih